Montbert, France

Pierre Corre

This inventor holds 1 USPTO granted patent. Top assignees: Chu Nantes, Institut National De La Santé Et De La Recherche Médicale (Inserm), Nantes Université. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pierre Corre. Retrieved from https://idiyas.com/inventor/pierre-corre-urp3by08

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Pierre Corre: Inventor in Bone Regeneration

Introduction

Pierre Corre is an inventor associated with Montbert, France. His work includes a patent for a printable material designed for bone regeneration and repair.

Latest Patents

Corre is credited with 1 patent: “Formulation comprising a phosphocalcic cement and a physical and/or covalent hydrogel of polysaccharides, printable and having ductile mechanical properties for bone regeneration/bone repair.” The invention combines phosphocalcic cement with a polysaccharide hydrogel to create a printable formulation with ductile mechanical properties.

Career Highlights

Corre is associated with Nantes Université and the French National Institute of Health and Medical Research (Inserm). His patent focuses on material formulation for potential applications in bone regeneration and repair.

Collaborations

His listed coworkers include Marie-Michèle Germaini and Pierre Weiss. Their names are associated with the collaborative research behind the patented formulation.

Conclusion

Pierre Corre’s patent work brings together printable phosphocalcic cement and polysaccharide hydrogel materials, with the aim of supporting bone regeneration and repair.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…